From Name:
From Email:
To Name:
To Email:

Optional Message:


Technion, Alpha Szenszor Partner to Commercialize Lung Cancer Diagnostics

from News-Medical.net

Alpha Szenszor, a leading provider of carbon nanotube based sensors and the Technion – Israel Institute of Technology have announced a joint venture for the commercialization of advanced lung cancer diagnostics based on volatile organic compound detection from human breath. The two organizations plan to merge expertise to commercialize an economically viable, noninvasive, digital tool for the early diagnosis of lung cancer. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063